The prices of the prescribed medicines continue to increase despite government intervention

president Donald Trump The executive order signed this week targeting the high costs that the United States pays for drugs compared to other developed countries. He stated that the matter will ensure that the United States will pay the lowest possible price for medicines that continued to get part of the consumer governor.

But while policymakers are trying for years to improve access to medicines and the ability to withstand costs, Tori Marsh, the chief research manager in Goodrx, confirmed how the costs are still a great burden for many.

According to goodrx data, The cost of healthcare Not only was inflation in general, but also the Americans’ income, which means that profits do not grow at the fastest health care expenses, which include prescribed medications.

From 2014 to 2017, the price of these drugs increased dramatically before climbing 3 % to 4 % at the beginning of each year. Since 2014, the costs of prescribed medicines increased by 39 %, according to Goodrx data.

Trump says that drug prices will be reduced by up to 90 %: What do you know

Last year, patients spent $ 61 billion on medical prescriptions outside the pocket, according to Marsh, who cited the costs of Goodrx medical prescriptions, which provides in an actual time at the high costs faced by Americans on a pharmacy.

Prices are partly due to health care enlargement, market dynamics and pricing strategies, according to Marsh.

“Pharmaceutical products are subject to complex pricing strategies, which often include high preliminary pricing and regular gradual increases,” she said.

Marsh said that the prescribed drugs “have witnessed inflation rates that exceed the total consumer price index, adding that the drugs are also subject to complex pricing strategies, which often include preliminary pricing and regular gradual increases.”

John Murphy, CEO of ASSOCRATION, said that high prices for branded drugs are responsible because it is the reason that the United States is paying more for prescribed medicines.

Trump signs the executive order that aims to enhance the manufacture of American prescribed drugs

These increases in pricing brand medicines are a “big problem” that leads to a set of costs that go beyond mere patients and employers who pay more, “according to Morphi.

Murphy said that the United States needed to do better in the use of public and biological medicines, which he said, “It should have always been under law.”

Public and biological drugs are manufactured and organized differently, although they are generally low -cost equation for branded drugs.

“Instead, often, brand drug prices are increasing throughout the year, even after the development costs have been recovered for a long time,” Murphy said.

He said that although limestone remains largely available, they consume only 13 % of American spending in the United States, adding that “trends in favor of brands for a longer period threaten this progress greatly.”

The United States not only needs to encourage the use of public medicines, but it also needs to implement policies that facilitate the entry of medicines to the market, according to Marsh.

Get Fox Business on the Go by clicking here

As of now, approximately 30 % of Americans are already able to fill the recipes due to high costs, leaving tens of millions a prescription in the pharmacy every month, according to Marsh.

While health care is often Covered with insurance, More cost burden is transferred to consumers as medical prescription insurance coverage becomes more complex and restricted.

According to GOODRX, the average medical care plan does not cover 44 % of the medications and imposes restrictions on nearly half of the covered drugs.

“This contributes to increasing the number of believers, which includes people with high health care costs in an inconsistent compared to their income, which exacerbates the issues of access to health care and disparity.” “Unfortunately, this trend is likely to continue to grow if things do not change.”